Description of Septic Thrombophlebitis on Central Venous Catheter and Midline (THROMBOSEP)
Septic Thrombophlebitis
About this trial
This is an interventional diagnostic trial for Septic Thrombophlebitis focused on measuring septic thrombophlebitis, Doppler ultrasound
Eligibility Criteria
Inclusion Criteria: Adult patient hospitalised at the CHM or CHUA, with a central venous device (Implantable chamber, central venous jugular, femoral, subclavian, PICCline, dialysis catheter) or a Midline and having catheter-related bacteremia Catheter-related bacteremia according to the following definition (ePOPI): Positive blood cultures within 48 hours of a suspected catheter infection (or its removal) With one of the following criteria: - Before catheter removal: differential time of positivity of central/peripheral blood cultures ≥ 2 hours After catheter removal: positive catheter culture ≥ 103 CFU/ml, with the same organism. Patient transportable for ultrasound or ultrasound can be performed in the patient's bed Patient capable of giving consent, or consent of the trusted person for patients not capable of giving consent at the time of inclusion Written consent signed by the participant and the investigator Person affiliated to social security Exclusion Criteria: Patient with a life expectancy of less than one month Contraindication to anticoagulation Patient already on curative anticoagulant therapy for any indication Minor or adult patient under guardianship or protected or deprived of liberty Pregnant, nursing or parturient woman
Sites / Locations
- CHU Angers
- Centre Hospitalier Le MansRecruiting
Arms of the Study
Arm 1
Arm 2
Other
No Intervention
Presence of thrombosis
Absence of thrombosis
Doppler ultrasound D8, D15, D30, D45, D60 and D90